Dr. Gilheeney is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1275 York Avenue
New York, NY 10065Phone+1 212-639-3973Fax+1 212-717-3239
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 2002 - 2005
- New York Presbyterian Hospital (Cornell Campus)Residency, Pediatrics, 1999 - 2002
- The Warren Alpert Medical School of Brown UniversityClass of 1999
Certifications & Licensure
- NY State Medical License 2000 - 2026
- NJ State Medical License 2024 - 2025
- MA State Medical License 2005 - 2006
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Perifosine With Temsirolimus for Recurrent Pediatric Solid Tumors Start of enrollment: 2010 Jan 01
Publications & Presentations
PubMed
- 17 citationsDebio1347, an Oral FGFR Inhibitor: Results From a Single-Center Study in Pediatric Patients With Recurrent or Refractory FGFR-Altered Gliomas.Sameer Farouk Sait, Stephen Gilheeney, Tejus Bale, Sofia Haque, Marc Dinkin
JCO Precision Oncology. 2021-05-20 - 250 citationsIntegrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade Gliomas.Scott Ryall, Michal Zapotocky, Kohei Fukuoka, Liana Nobre, Ana Guerreiro Stucklin
Cancer Cell. 2020-04-13 - 50 citationsReirradiation for recurrent medulloblastoma.Richard L. Bakst, Ira J. Dunkel, Stephen Gilheeney, Yasmin Khakoo, Oren J. Becher
Cancer. 2011-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: